Literature DB >> 6424118

Identification of a sulfate-bearing molecule associated with HLA class II antigens.

A J Sant, S E Cullen, B D Schwartz.   

Abstract

The human Ia antigens (DR, DS, and SB), determined by genes contained within the HLA complex on chromosome 6, are glycoprotein heterodimers consisting of a Mr approximately equal to 34,000 alpha chain and a Mr approximately equal to 28,000 beta chain. As a result of studies exploring the possibility that alpha or beta (or both) might be sulfated, a unique component of the oligomeric Ia antigen complex was discovered. When anti-Ia immunoprecipitates from Nonidet P-40 lysates of [35S]sulfate-labeled lymphoid cells were analyzed by NaDodSO4/PAGE, a molecule of considerable size heterogeneity (Mr 40,000-70,000) was observed. This component was present in both anti-DR and anti-DS immunoprecipitates prepared from both human tonsil cells and lymphoblastoid B-cell lines but was not observed in control precipitates or in association with immunoglobulin or class I HLA molecules. Preliminary biochemical studies indicate that this Mr 40,000-70,000 molecule is polyanionic, disperse in molecular weight, and sensitive to protease digestion. The sulfate-bearing moiety of this component was resistant to Pronase but sensitive to chondroitinase ABC, indicating that this molecule belongs to the chondroitin sulfate class of proteoglycans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424118      PMCID: PMC344871          DOI: 10.1073/pnas.81.5.1534

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

2.  Isolation and partial characterization of sialoglycopeptides produced by a murine melanoma.

Authors:  V P Bhavanandan; J Umemoto; J R Banks; E A Davidson
Journal:  Biochemistry       Date:  1977-10-04       Impact factor: 3.162

3.  Structure of the carbohydrate units of IgA1 immunoglobulin. II. Structure of the O-glycosidically linked oligosaccharide units.

Authors:  J Baenziger; S Kornfeld
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

4.  Heterogeneity of proteochondroitin sulfates produced by chondrocytes at different stages of cytodifferentiation.

Authors:  K Kimata; M Okayama; A Ooira; S Suzuki
Journal:  J Biol Chem       Date:  1974-03-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  HLA-D associated alloantisera react with molecules similar to Ia antigens.

Authors:  M J Giphart; J F Kaufman; A Fuks; D Albrechtsen; B G Solheim; J W Bruning; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

7.  Antisera to human B-lymphocyte membrane glycoproteins block stimulation in mixed lymphocyte culture.

Authors:  P Cresswell; S S Geler
Journal:  Nature       Date:  1975-09-11       Impact factor: 49.962

8.  Purification and properties of an extracellular protease of Staphylococcus aureus.

Authors:  G R Drapeau; Y Boily; J Houmard
Journal:  J Biol Chem       Date:  1972-10-25       Impact factor: 5.157

9.  An improved method for isolation of H-2 and Ia alloantigens with immunoprecipitation induced by protein A-bearing staphylococci.

Authors:  S E Cullen; B D Schwartz
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

10.  Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis.

Authors:  D A Shackelford; J L Strominger
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  9 in total

1.  Role for intracellular proteases in the processing and transport of class II HLA antigens.

Authors:  J S Blum; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins.

Authors:  M A Bourdon; T Krusius; S Campbell; N B Schwartz; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Identification of the glycosaminoglycan-attachment site of mouse invariant-chain proteoglycan core protein by site-directed mutagenesis.

Authors:  J Miller; J A Hatch; S Simonis; S E Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  Conservation of a polyanion binding site in mammalian and avian CD4.

Authors:  C R Parish; H S Warren
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

5.  The human invariant chain is the core protein of the human class II-associated proteoglycan.

Authors:  K S Giacoletto; A J Sant; C Bono; J Gorka; D M O'Sullivan; V Quaranta; B D Schwartz
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

6.  Membrane-associated chondroitin sulfate proteoglycans of human lung fibroblasts.

Authors:  G David; V Lories; A Heremans; B Van der Schueren; J J Cassiman; H Van den Berghe
Journal:  J Cell Biol       Date:  1989-03       Impact factor: 10.539

7.  Invariant chain is the core protein of the Ia-associated chondroitin sulfate proteoglycan.

Authors:  A J Sant; S E Cullen; K S Giacoletto; B D Schwartz
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

8.  RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.

Authors:  J B McCarthy; A P Skubitz; Z Qi; X Y Yi; D J Mickelson; D J Klein; L T Furcht
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

9.  Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes.

Authors:  I I Singer; S Scott; G L Hall; G Limjuco; J Chin; J A Schmidt
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.